Guan Chong Berhad operates within the Candy & other confectionery products sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Guan Chong Berhad with three other
bakery and confectionary companies in Asia:
GlaxoSmithKline Consumer Healthcare Limited
sales of 39.86 billion Indian Rupees [US$614.71 million]
of which 100%
Nakamuraya Co., Ltd.
(41.90 billion Japanese Yen [US$394.29 million]
of which 71%
was Confectionery Business), and
Imuraya Group Company Limited
based in Japan
(42.00 billion Japanese Yen [US$395.20 million]
of which 88%
was Distribution Business).
During the year ended December of 2017, sales at
Guan Chong Berhad were 2.15 billion Malaysian Ringgits (US$550.52 million).
decrease of 7.1%
versus 2016, when the company's sales were 2.32 billion Malaysian Ringgits.